BRIEF-biOasis enters into a license agreement with Vaccinex Inc.
September 20, 2016 at 21:26 PM EDT
* biOasis Technologies Inc - Says under terms of agreement, Vaccinex will have right to commercialize its anti-Semaphorin 4D antibody technology